Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
MeSH Number(s)
B04.820.455.600.670.600.750.730
B04.909.777.455.600.670.600.750.730
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in Harvard Catalyst Profiles by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 1 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 5 | 1 | 6 |
| 2020 | 5 | 2 | 7 |
| 2021 | 8 | 3 | 11 |
| 2022 | 12 | 1 | 13 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
The Maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation. Proc Natl Acad Sci U S A. 2023 Jan 10; 120(2):e2206480120.
-
A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults. J Infect Dis. 2022 12 13; 226(12):2054-2063.
-
Antibody effector functions are associated with protection from respiratory syncytial virus. Cell. 2022 Dec 22; 185(26):4873-4886.e10.
-
An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease. Viruses. 2022 09 20; 14(10).
-
Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis. J Infect Dis. 2022 08 15; 226(Suppl 2):S236-S245.
-
Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection. Clin Infect Dis. 2022 08 15; 75(Suppl 1):S130-S135.
-
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns. Nat Commun. 2022 08 02; 13(1):4234.
-
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine. J Infect Dis. 2022 06 15; 225(12):2056-2066.
-
Respiratory viruses in rural Zambia before and during the COVID-19 pandemic. Trop Med Int Health. 2022 07; 27(7):647-654.
-
Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma. Allergy. 2022 Nov; 77(11):3350-3361.